eCFR Reference Browser

---

title: "21 CFR §870.3375"

source: "https://www.ecfr.gov/current/title-21/section-870.3375"

title_number: "21"

volume_number: "8"

chapter_number: "Unknown"

subchapter_code: "H"

subchapter_subject: "MEDICAL DEVICES"

part_code: "870"

part_subject: "CARDIOVASCULAR DEVICES"

subpart_code: "D"

subpart_subject: "Cardiovascular Prosthetic Devices"

section_number: "870.3375"

section_subject: "Cardiovascular intravascular filter."

cfr_reference: "21 CFR 870.3375"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 800 to 1299"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

(a)Identification. A cardiovascular intravascular filter is an implant that is placed in the inferior vena cava for the purpose of preventing pulmonary thromboemboli (blood clots generated in the lower limbs and broken loose into the blood stream) from flowing into the right side of the heart and the pulmonary circulation.

(b)Classification. Class II. The special controls for this device are:

(1)“Use of International Standards Organization's ISO 10993 ‘Biological Evaluation of Medical Devices Part I: Evaluation and Testing,’ ” and

(2)FDA's:

(i)“510(k) Sterility Review Guidance and Revision of 2/12/90 (K90-1)” and

(ii)“Guidance for Cardiovascular Intravascular Filter 510(k) Submissions.”

§870.3375 - Cardiovascular intravascular filter.